89bio Stock (NASDAQ: ETNB) stock price, news, charts, stock research, profile.
Open | $8.59 |
Close | $8.86 |
Volume / Avg. | 349.30K / 963.08K |
Day Range | $8.45 - $8.88 |
52 Wk Range | 6.58 - 18.30 |
Market Cap | $871.19M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 8.69% |
Days to Cover | 8.69 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of 89bio (NASDAQ:ETNB) through any online brokerage.
Other companies in 89bio’s space includes: Immunome (NASDAQ:IMNM), Humacyte (NASDAQ:HUMA), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT) and Cogent Biosciences (NASDAQ:COGT).
89bio has a consensus price target of $29.60.
The stock price for 89bio (NASDAQ: ETNB) is $8.855 last updated August 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for 89bio.
89bio’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for 89bio.
89bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.